ResearcherCentre Hospitalier Universitaire VaudoisNo recent work listed

Michal Bassani‐Sternberg

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1934-954X; OpenAlex author ID A5087479651. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper

Papers 1

A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivoluma… Co-author DOI 10.3389/fimmu.2019.01832 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Antonia Digklia · 1 shared paper, 2019 · strength 0.08
- Paper A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Ad… DOI 10.3389/fimmu.2019.01832 ↗
Nicolas Demartines · 1 shared paper, 2019 · strength 0.08
- Paper A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Ad… DOI 10.3389/fimmu.2019.01832 ↗
Lana Elias Kandalaft · 1 shared paper, 2019 · strength 0.08
- Paper A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Ad… DOI 10.3389/fimmu.2019.01832 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.